NCT04317404View on ClinicalTrials.gov

Knee Steroid Injection and Blood Sugar Signatur

CompletedOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

November 30, 2022

Study Completion Date

November 30, 2022

Conditions
DiabetesKnee Osteoarthritis
Interventions
DRUG

40 mg Triamcinolone acetonide

Unilateral knee steroid injection

Trial Locations (1)

75235

Parkland Hospital, Dallas

All Listed Sponsors
collaborator

Foundation for Physical Medicine and Rehabilitation

OTHER

lead

University of Texas Southwestern Medical Center

OTHER

NCT04317404 - Knee Steroid Injection and Blood Sugar Signatur | Biotech Hunter | Biotech Hunter